ATLASvTv Therapeutics (VTVT) earnings date: Nov 5, 2026
vTv Therapeutics (VTVT) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026. Analysts expect EPS of -$1.07.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on VTVT
| Last price | $23.84 (-5.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.3% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 5 reports |
These figures come from the same calibrated model and valuation as the vTv Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
vTv Therapeutics reports on Nov 5, 2026. One email the day before, with ATLAS’s read on vTv Therapeutics. You can switch it off at any time.
Alert me before VTVT reportsFree to start. Creating an account takes under a minute.
Notify me when vTv Therapeutics reports
Track VTVT free Add vTv Therapeutics to a free ATLAS watchlist and see its next report date in one place.
VTVT earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.07 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 5 reports) | 4 of 5 (80%) |
| Average EPS surprise | +151.9% |
| Average move around a report | ±6.0% (last 5) |
| Sector | Healthcare · Biotechnology |
vTv Therapeutics earnings history: last 5 reports
vTv Therapeutics last reported on Aug 6, 2026: EPS of -$1.05 against an estimate of -$1.08 (+2.8% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$1.08 | -$1.05 | +2.8% | Beat | +2.9% |
| May 29, 2026 | $0.74 | $0.92 | +24.3% | Beat | +2.4% |
| May 13, 2026 | $0.21 | $1.65 | +685.7% | Beat | +19.7% |
| Apr 16, 2026 | $1.15 | $1.15 | 0.0% | In line | +1.1% |
| Mar 10, 2026 | -$1.09 | -$0.58 | +46.8% | Beat | -3.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for VTVT
See the fair value, the probability range and the earnings history of vTv Therapeutics on its ATLAS page.
vTv Therapeutics (VTVT) stock analysisPlans from €3.99 a month.
vTv Therapeutics earnings: frequently asked questions
When does vTv Therapeutics (VTVT) report earnings?
vTv Therapeutics is scheduled to report on Thursday, November 5, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for VTVT?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.07 per share (USD). Estimates can change before the report.
How often does VTVT beat earnings estimates?
Of its last 5 reports with a recorded result, vTv Therapeutics beat the EPS estimate 4 times; the average surprise was +151.9%. Past results do not predict the next one.
How much does VTVT move around earnings?
Over its last 5 reports the stock moved an average of 6.0% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did vTv Therapeutics beat earnings estimates last quarter?
vTv Therapeutics last reported on Aug 6, 2026: EPS of -$1.05 against an estimate of -$1.08 (+2.8% surprise), a beat.
How much does VTVT usually move in a day?
On a normal trading day the ATLAS model puts VTVT’s one-day range at about ±3.3%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer